Leukemia Clinical Trials

1. (ILEU05010) A Phase I/II Study of SKI-606 in Philadelphia Chromosome Positive Leukemias
2. (CLEU08043) (CALGB-10501)- A Phase III Intergroup CLL Study of Asymotomatic Patients with Untreated Chronic Lymphocytic Leukemia Randomized to Early Intervention Versus Observation with Later Treatment in the High-Risk Genetic Subset with IGVH Unmutated Disease.
3. (CLEU05001) (S0333)A Phase II Study of Double Induction Chemotherapy for Newly Diagnosed No-L3 Adult Acute Lymphoblastic Leukemia with Investigation of Minimal Residual Disease and Risk of Relapse Following Maintenance Chemotherapy
4. (CLEU05001) (S0333)A Phase II Study of Double Induction Chemotherapy for Newly Diagnosed No-L3 Adult Acute Lymphoblastic Leukemia with Investigation of Minimal Residual Disease and Risk of Relapse Following Maintenance Chemotherapy
5. (CLEU08081) A Phase III Randomized, Double-Blind Study of Induction (Daunorubicin/Cytarabine) and Consolidation (High-Dose Cytarabine) Chemotherapy + Midostaurin (PKC412) (IND #101261) or Placebo in Newly Diagnosed Patients < 60 Years of Age with FLT3 Mutated Acute Myeloid Leukemia (AML).